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ABSTRACT
Adolescents with perinatal HIV (PHIV) may be at higher risk of anxiety and depression than HIV
negative young people. We investigated prevalence of anxiety and depression symptoms in 283
PHIV and 96 HIV-affected (HIV-negative) young people in England recruited into the Adolescents
and Adults Living with Perinatal HIV (AALPHI) cohort. We used Hospital Anxiety and Depression
Scale (HADS) scores and linear regression investigated predictors of higher (worse) scores.115 (41%)
and 29 (30%) PHIV and HIV-affected young people were male, median age was 16 [interquartile
range 15,18] and 16 [14,18] years and 241 (85%) and 71 (74%) were black African, respectively.
There were no differences in anxiety and depression scores between PHIV and HIV-affected
participants. Predictors of higher anxiety scores were a higher number of carers in childhood,
speaking a language other than English at home, lower self-esteem, ever thinking life was not
worth living and lower social functioning. Predictors of higher depression scores were male sex,
death of one/both parents, school exclusion, lower self-esteem and lower social functioning. In
conclusion, HIV status was not associated with anxiety or depression scores, but findings highlight
the need to identify and support young people at higher risk of anxiety and depression.
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Introduction
Developmental and etiological models of anxiety suggest
exposure to uncontrollable life events in early life may
lead individuals to perceive events as out of their control.
This can lead to a vulnerability for anxiety and possible
subsequent depression (Chorpita & Barlow, 1998).
Young people with perinatal HIV (PHIV) may be at
increased risk of anxiety and depression compared to
other adolescents (Gadow et al., 2010, 2012; Malee
et al., 2011; Mellins et al., 2012; Mellins & Malee, 2013)
because of a complex mix of psycho-social issues and
biomedical factors that are associated with chronic ill-
ness. Additionally, there may be a greater number of
uncontrollable adverse factors which may affect mental
health in this group. Having an understanding of the
prevalence and risk factors for anxiety and depression
among young people with PHIV, and comparison to
HIV-affected young people can help ensure that appro-
priate support can be provided.
In the UK, 50% of a sample of 3258 adults with HIV
had anxiety and depression, compared to around a quar-
ter in a study of 8503 adults from the general population
(Miners et al., 2014). However studies in children and
adolescents with HIV in Europe have been limited by
small sample sizes and a lack of general population or
HIV-affected comparison groups (Bomba et al., 2010;
Funck-Brentano et al., 2016). Several large sub-Saharan
African studies have investigated mental health problems
in HIV+ young people (known or assumed to be PHIV)
(Dow et al., 2016; Kim et al., 2015; Mutumba et al.,
2017; Woollett, Cluver, Bandeira, & Brahmbhatt, 2017).
In a South Africanmulti-clinic study of 343 young people
27% had symptoms of anxiety, depression or post-trau-
matic syndrome (PTSD) (Woollett et al., 2017). In Tanza-
nia 12%of 182 adolescents in a single clinic had depressive
symptoms, 10% emotional and behavioural symptoms
and 14% PTSD (Dow et al., 2016). Similarly in a large
multi-clinic study in Malawi including 562 young people
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19%had depressive symptomology (Kim et al., 2015). The
majority of studies with an HIV-affected comparator are
from the USA. Perhaps surprisingly, most recent USA
based studies found no evidence of greater mental health
problems in PHIV compared to HIV-affected (perinatally
HIV exposed or HIV affected), young people, but higher
prevalence in both PHIV and HIV-affected groups com-
pared to the general population (Gadow et al., 2010,
2012; Malee et al., 2011; Mellins et al., 2012). These find-
ings highlight the importance of including appropriate
control groups in interpreting study findings (Elkington
et al., 2011; Vreeman, McCoy, & Lee, 2017).
We investigated the prevalence of symptoms of
anxiety and depression and explored associations with
a wide range of psychosocial factors, in older adolescents
with and without PHIV in England. This is the first mod-
erately sized study with a comparator group to investi-
gate this issue in England or Europe.
Methods
The Adolescents and Adults Living with Perinatal HIV
(AALPHI) cohort is a prospective study evaluating the
impact of HIV and antiretroviral (ART) exposure on
young people with PHIV and HIV negative young
people affected by HIV. Detailed methods have been
reported elsewhere (Judd et al., 2016). Participants
were enrolled between 2013 and 2015 from HIV clinics
and community services in England and underwent a
two-hour face-to-face interview, including computer-
assisted survey interviewing for sensitive questions,
after giving informed consent. Ethical approval was
obtained from Leicester Research Ethics Committee.
PHIV participants were aged 13–21 years. HIV-
affected young people were: aged 13–23 years; HIV
negative on a point-of-care test at interview; living in
the same household as a PHIV participant in AALPHI,
or had a sibling, friend or partner who was a PHIV par-
ticipant in AALPHI, or had an HIV positive parent;
and awareness of HIV in the family (where appropri-
ate). HIV-affected participants born to mothers with
HIV may have been exposed to HIV and/or ART in
utero but it was not possible to confirm in which par-
ticipants this was the case. All participants had lived in
the UK for ≥6 months and could speak and understand
English.
Anxiety and depression scores were measured using
the Hospital Anxiety and Depression Scale (HADS) (Zig-
mond & Snaith, 1983). Scores range from 0 to 21, with
higher scores indicating more severe anxiety or
depression. Scores were categorised using standard defi-
nitions as normal (<7), mild (8–10), moderate (11–15) or
severe (>15) (Zigmond & Snaith, 1983). Self-esteem was
measured using the Rosenberg self-esteem scale (scores
range from 0 to 30: higher scores indicate better self-
esteem) (Rosenberg, 1965). Normative data sources for
HADS and self-esteem are detailed in Supplementary
Table 1. A residential deprivation score measured depri-
vation (Income Deprivation Affecting Children Index
(IDACI), ranging from 0 to 1; higher score indicates
more severe deprivation) (Department for Communities
and Local Government, 2011). Social support was
measured using the Social Functioning score from the
Pediatric Quality of Life Inventory (PedsQL) (Teenage
report for 13–18 and Young Adult report for 18–25
years); scores range from 0 to 100 and a higher score
indicates better social functioning (Varni, 2012).
A cognitive composite of executive functions (neu-
ropsychological scores (NPZ score)) was calculated
using manufacturer normative data for six domains
(executive function; speed of information processing;
attention/working memory, learning and memory and
fine motor skills) and the mean across these domains
was calculated (NPZ-6) (further details of the individual
cognitive test are available in Judd et al., 2016).
For the PHIV group only the effect of the following
HIV-related health factors on anxiety and depression
scores were considered: age diagnosed with HIV, age
starting ART and current ART status, current efavirenz
(EFV) use (due to potential association with
depression), nadir and most recent CD4 cell count,
most recent viral load ≤50 copies/mL vs. >50 copies/
mL, median cumulative years with viral load
<400 copies/mL, HIV disclosure factors (age told HIV
status and ever told anyone HIV status) and current
feeling about HIV status.
Statistical analysis
Data were analysed using STATA version 13 (Stata Corp,
College Station, Texas, USA).
Descriptive statistics (χ2, Mann–Whitney Wilcoxon
Test) summarised sociodemographic and HADS data
by HIV status.
Linear regression andWald p-values assessed poten-
tial associations between variables and anxiety/
depression scores. Variables which attained p < 0.15
in univariable analyses were considered for inclusion
in multivariable analyses using backwards selection.
All multivariable models included HIV status as
well as a priori factors associated with anxiety and
depression scores (sex, age, ethnicity, born abroad). A
two-tailed p value of <0.05 was considered statistically
significant. Other variables considered in the analysis
were selected on the basis of the literature and are listed
in Table 1.
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A model for young people with PHIV only addition-
ally considered the effect of HIV-related health factors
on anxiety and depression scores (Table 5).
Three sensitivity analyses were conducted. Firstly, for
young people with PHIV only, we included all variables
which were significant in the overall models as well as the
HIV-related variables, to check that loss of power from
the reduced sample size was not affecting model out-
comes. Secondly, due to the potential for mental health
variables to be outcomes of anxiety and depression
rather than antecedents, sensitivity analyses excluded
these variables from the models. Thirdly, we restricted
the models to ≥16 years only to investigate any potential
effect of using HADS, WAIS-IV and Color Trails 1 and 2
scales for those aged <16 years of age.
Results
A total of 283 PHIV and 96 HIV-affected participants
completed HADS. Of the 96 HIV-affected young people,
46 (48%) had a mother with HIV, 38 (40%) were siblings
of young people with PHIV in the study, 8 (8%) had
PHIV siblings who were not in the study, and 4 (4%)
had a close friend who was a young person with PHIV.
Sociodemographic characteristics of the two groups
were generally similar (Table 1). Two-thirds were female,
median age overall was 16 years, most were black African
and born outside of the UK. For around a quarter (24%)
of HIV-affected young people, one or both parents had
died, compared to 37% for the PHIV group. Mean scores
for self-esteem were similar across both groups, 12% of
PHIV and 19% of HIV-affected participants have ever
self-harmed, and 39% in both groups reported ever feel-
ing life was not worth living. Similar proportions
reported having ever smoked and used alcohol, while
the proportion ever using recreational drugs was 15%
in PHIV and 29% in HIV-affected participants (p =
0.003).
For the PHIV group, median age at first presentation
to care in the UK was 4 years [interquartile range (IQR)
0,8] (Table 2). Median nadir CD4 was 226 c/mm3
[128,367] and CD4 at interview 599 c/mm3 [407,782].
Around three-quarters of those on ART (74%) had
never had a CDC C event and 87% were on ART at inter-
view. Around three-quarters (74%, 177/238) had a viral
load ≤50 c/mL at interview, median age at start of
ART was 7 years [3,11] and median cumulative number
of years with a suppressed viral load (<400 c/mL) was 6
years [3,9].
Figure 1 presents anxiety and depression scores by
HIV status. Around two-thirds (60% PHIV vs 69%
HIV-affected, p = 0.145) scored in the “normal” range
for anxiety, and similarly around four-fifths (84% vs
83% respectively, p = 0.795) for depression. Only four
PHIV and two HIV-affected participants had a “severe”
score for anxiety and none for depression.
Raw and z-score adjusted anxiety and depression
mean scores did not differ between PHIV and HIV-
affected participants (all p values ≥0.1; Table 3) and
were very close to the UK population means. For self-
esteem, similarly, there were no differences in raw and
z-scores between PHIV and HIV-affected participants
Table 1. Characteristics of PHIV+ and HIV- participants.
PHIV+ (n = 283) HIV- (n = 96)
P-
value
n (%) or median [interquartile range
(IQR)] or mean {standard deviation (SD)}
A-priori:
Female sex 168 (59%) 67 (70%) 0.069
Age group
≤15 years 105 (37%) 40 (42%) 0.582
16–18 years 117 (41%) 34 (35%)
≥19 years 61 (22%) 22 (23%)
Median 16 [15,18] 16 [14,18] 0.784
Black ethnicity 241 (85%) 71 (74%) 0.013
Born outside United
Kingdom/Ireland
161 (57%) 46 (48%) 0.127
Demographic:
Occupation
School 261 (92%) 86 (90%) 0.298
Employment 8 (3%) 6 (6%)
Not in education or
training
14 (5%) 4 (4%)
Main language spoken at home
English only 150 (53%) 44 (46%) 0.322
English and another
language
127 (45%) 48 (50%)
A language other than
English
6 (2%) 4 (4%)
Number of years in the UK (n = 247, n = 65)
Born in UK 122 (49%) 50 (77%) <0.001
In UK <5 years 42 (17%) 5 (8%)
In UK ≥5 years 83 (34%) 10 (15%)
Recruited outside London 78 (28%) 25 (26%) 0.772
Family:
Live with parents/carers 256 (90%) 85 (88%) 0.589
Fostered/adopted (n =
123, n = 43)
11 (9%) 0 0% 0.040
Number of main carers
Median 1 [1,2] 1 [1,2] 0.221
≥3 main carers 41 (15%) 17 (18%) 0.449
Parent/carer in work 202 (73%) 57 (61%) 0.030
Negative life events:
Death of one or both
parents
98 (37%) 22 (24%) 0.024
Ever excluded from school 47 (17%) 20 (21%) 0.348
Income Deprivation
Affecting Children Index
(IDACI) (n = 249, n = 74)
0.38 {0.18} 0.46 {0.15} 0.002
Behavioural:
Ever smoked 53 (19%) 23 (25%) 0.248
Ever had alcohol 116 (42%) 41 (44%) 0.709
Ever used recreational
drugs
41 (15%) 26 (29%) 0.003
Mental health/psychological:
Ever self-harmed 35 (12%) 18 (19%) 0.277
Ever felt life not worth
living
111 (39%) 37 (39%) 0.900
PedsQL Social function 86.49 {15.69} 88.42 {14.30} 0.290
Cognition:
Neuropsychological
(NPZ6) score
−0.41 [−0.99,0.12] −0.24 [−0.76, 0.24] 0.077
Note: Denominator given when >10% missing data for this variable.
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(both p values > 0.8), although mean z-scores for both
groups were nearly two standard deviations lower than
the population means.
In a multivariable model for anxiety, there was no evi-
dence for young people with PHIV having greater
anxiety scores than HIV-affected young people (multi-
variable coefficient 0.14, 95%CI −0.03, 0.31; Table 4).
Speaking a language other than English at home (0.48,
95%CI 0.01, 0.95), having a higher number of main
carers (0.06, 95%CI 0.02,0.10), having ever thought life
was not worth living (0.26, 95%CI 0.09,0.43) lower
self-esteem scores (−1.27, 95%CI −1.60,−0.95, 001 per
5 unit increase) and lower social functioning scores
(−0.22, 95%CI −0.35,−0.08 per 25 unit increase) were
associated with an increased number of anxiety scores.
For depression, there were no differences in scores
between PHIV and HIV-affected participants (multivari-
able coefficient 0.08, 95%CI −0.10, 0.25). Being male
(female −0.29, 95%CI −0.45,−0.13), death of one or
both parents (0.23, 95%CI 0.07, 0.39), ever being
excluded from school (0.27, 95%CI 0.07, 0.47), lower
self-esteem scores (−1.52, 95%CI −1.83,−1.20 per 5
unit increase) and lower social functioning scores
(−0.14, 95%CI −0.27,−0.01 per 25 unit increase) were
associated with a higher number of depression scores.
Table 2. HIV-related health factors for PHIV+ participants.
PHIV+ (n = 290)
n (%) or median
[interquartile range
(IQR)]
Age at first presentation 4 [1, 9]
Age at initiation of ART (on or off ART only), years 7 [3, 11]
Age told HIV status, years 12 [11, 13]
CD4 cell count, cells/µL
Nadir 226 [128, 367]
At interview 599 [407, 782]
Viral load at interview (if on ART), copies/mL
≤ 50 181 (66%)
>50 94 (34%)
Cumulative time with viral load <400, years 6 [3, 9]
CDC status at interview
N/A 134 (47%)
B 76 (27%)
C 72 (26%)
ART status at interview
Naïve 24 (9%)
On ART 238 (86%)
Off ART (but previously taken) 13 (5%)
Efavirenz use at interview (on ART only)
Never or previously had efavirenz 207 (73%)
On efavirenz now 75 (27%)
Figure 1. Anxiety and depression symptom raw scores by HIV status.
Table 3. Raw and adjusted anxiety, depression and self esteem
scores, for PHIV+ and HIV- participants.
PHIV+
(n = 283) HIV- (n = 96) T testa
Mean SD Mean SD p value
Anxietyb Raw score 6.49 3.92 5.98 4.06 0.274
z-score Crawfordd
(all ages)
−0.09 1.04 0.04 1.08 0.274
z-score Breemane
(age 25–29)
−0.02 0.84 −0.17 0.88 0.139
Depressionb Raw score 3.93 3.13 3.52 2.94 0.259
z-score Crawfordd
(all ages)
0.08 1.02 −0.05 0.96 0.259
z-score Breemane
(age 25–29)
0.11 0.85 −0.03 0.77 0.166
Self esteemc Raw score 20.51 5.50 20.60 5.89 0.881
z-score Gabhainnf −1.93 1.58 −1.92 1.70 0.935
aTwo sided t-test.
bHigher score = worse anxiety/ depression.
cHigher score = better self-esteem.
dNormative data: adults in the UK with mean age 41.5 (SD 15.9) adjusted for
sex (Crawford, Henry, Crombie, & Taylor, 2001, pp. 429–434).
eNormative data: adults in the UK aged 25–29 years adjusted for sex (Bree-
man et al., 2015, pp. 391–398).
fNormative data: young people in Ireland, adjusted for age group (13–14, 15–
17 years (norms for 15–17 years were used for those >17 in AALPHI)) and
sex (Gabhainn & Mullan, 2003, pp. 829–830).
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Table 4. Univariable and multivariable predictors of increased anxiety and depression scores.
Variable
Anxiety Depression
Univariable Multivariable Univariable Multivariable
Coeff* 95% CI** p*** Coeff 95% CI p Coeff 95% CI p Coeff 95% CI p
HIV status, PHIV+
(v. HIV-)
0.15 −0.05, 0.35 0.139 0.14 −0.03, 0.31 0.102 0.14 −0.06, 0.33 0.166 0.08 −0.10, 0.25 0.387
A-priori:
Female sex
(v. male)
0.21 0.03, 0.39 0.019 −0.11 −0.26, 0.05 0.193 −0.07 −0.24, 0.10 0.425 −0.29 −0.45, −0.13 0.001
Age
(per year increase)
0.02 −0.02, 0.05 0.362 0.02 −0.01, 0.05 0.202 −0.01 −0.04, 0.02 0.589 −0.02 −0.05, 0.01 0.290
Black African ethnicity
(v. other)
0.01 −0.22, 0.23 0.948 0.05 −0.15, 0.24 0.615 −0.01 −0.23, 0.21 0.960 −0.01 −0.21, 0.18 0.890
Born outside UK/Ireland
(v. UK born)
0.09 −0.08, 0.26 0.302 −0.11 −0.27, 0.05 0.159 0.18 0.02, 0.35 0.031 0.10 −0.06, 0.25 0.213
Demographic:
Language
Language other than English
(v. English only)
0.56 0.02, 1.10 0.041 0.48 0.01, 0.95 0.047 – – – – – –
Recruited outside London
(v. inside London)
– – – – – – 0.16 −0.03, 0.35 0.092 – – –
Family:
Live with parents/carers −0.26 −0.55, 0.03 0.075 – – – – – – – – –
Number of main carers
(per 1 carer increase)
0.09 −0.04, 0.14 0.001 0.06 0.02, 0.10 0.006 0.07 0.02, 0.12 0.004 – – –
Negative life events:
Death of parents
(one or both v. none)
0.15 −0.03, 0.34 0.106 – – – 0.26 0.08, 0.44 0.005 0.23 0.07, 0.39 0.004
Ever excluded from school – – – – – – 0.26 0.05, 0.48 0.018 0.27 0.07, 0.47 0.008
Behavioural:
Ever had alcohol – – – – – – −0.17 −0.34, −0.002 0.048 – – –
Ever had recreational drugs 0.17 −0.06, 0.40 0.143 – – – – – – – – –
Mental health/psychological:
Rosenberg self-esteem
(per 5 unit increase)
−1.48 −1.75, −1.21 <0.001 −1.27 −1.60, −0.95 <0.001 −1.41 −1.68, −1.15 <0.001 −1.51 −1.83, −1.20 <0.001
Ever self-harm 0.36 0.11, 0.61 0.004 – – – – – – – – –
Ever thought life not worth living 0.66 0.50, 0.83 <0.001 0.26 0.09, 0.43 0.003 0.38 0.21, 0.54 <0.001 – – –
PedsQL Social functioning
(per 25 point increase)
−0.54 −0.67, −0.41 <0.001 −0.22 −0.35, −0.08 0.002 −0.39 −0.52, −0.26 <0.001 −0.14 −0.28, −0.01 0.033
Cognition:
Neuropsychological (NPZ6) score
(per 5 unit increase)
– – – – – – −0.14 −0.24, −0.03 0.010 – – –
*Coefficient **Confidence Interval ***p value.
All a priori variables (HIV status, sex, age, ethnicity, born outside UK), as well as those with univariable p < 0.15 or multivariable p < 0.05 are presented here.
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Table 5. Univariable and multivariable predictors of increased anxiety and depression scores for PHIV+ only.
Variable
Anxiety Depression
Univariable Multivariable Univariable Multivariable
Coeff* 95% CI** p*** Coeff 95% CI p Coeff 95% CI p Coeff 95% CI p
A priori:
Female sex
(v. male)
0.22 0.02, 0.42 0.032 −0.10 −0.28, 0.09 0.296 −0.10 −0.30, 0.10 0.334 −0.32 −0.51, −0.13 0.001
Age
(per year increase)
0.04 −0.01, 0.08 0.110 0.03 −0.003, 0.07 0.073 −0.003 −0.05, 0.04 0.881 −0.03 −0.07, 0.01 0.141
Black African ethnicity
(v. other)
0.07 −0.20, 0.35 0.604 0.17 −0.07, 0.41 0.159 −0.04 −0.24, 0.32 0.781 0.12 −0.13, 0.37 0.332
Born outside UK/Ireland
(v. UK born)
0.01 −0.19, 0.21 0.920 −0.07 −0.24, 0.11 0.454 0.12 −0.08, 0.32 0.244 −0.01 −0.20, 0.17 0.883
Family:
Currently live with parents/carers −0.36 −0.70, −0.04 0.030 – – – – – – – – –
Number of main carers
(per 1 carer increase)
0.07 0.01, 0.14 0.034 0.06 0.001, 0.12 0.045 – – – – – –
Negative life events:
Ever excluded from school – – – – – – 0.23 −0.04, 0.49 0.090 – – –
Death of parents
(one or both v. none)
– – – – – – 0.30 0.09, 0.51 0.005 0.31 0.12, 0.49 0.001
IDACI deprivation score 0.05 −0.01, 0.11 0.085 – – – – – – – – –
Lifestyle factors:
Ever had alcohol – – – – – – −0.18 −0.39, 0.02 0.078 – – –
Mental health/psychological:
Rosenberg self-esteem
(per 5 unit increase)
−1.45 −1.78, −1.14 <0.001 −1.27 −1.66, −0.89 <0.001 −1.43 −1.75, −1.11 <0.001 −1.43 −1.77, −1.10 <0.001
Ever thought life not worth living 0.64 0.46, 0.83 <0.001 0.26 0.06, 0.45 0.010 0.31 0.11, 0.51 0.003 – – –
PedsQL Social Functioning
(per 25 unit increase)
−0.48 −0.62, −0.33 <0.001 −0.22 −0.35, −0.05 0.010 −0.35 −0.50, −0.20 <0.001 – – –
Cognition:
Neuropsychological (NPZ6) score (per 5 unit increase) – – – – – – −0.12 −0.24, 0.01 0.060 – – –
Current feelings about HIV:
(all per 1 point increase)
How upset about HIV −0.05 −0.08, −0.02 <0.001 – – – −0.04 −0.07, −0.01 0.006 – – –
How often think about HIV −0.06 −0.09, −0.26 <0.001 – – – −0.03 −0.06, 0.0005 0.054 – – –
How sad about HIV −0.06 −0.09, −0.03 <0.001 – – – −0.05 −0.08, −0.02 0.001 – – –
How supported −0.05 −0.08, −0.03 <0.001 – – – −0.06 −0.09, −0.03 <0.001 −0.04 −0.06, −0.01 0.008
Worry about future health −0.06 −0.09, −0.04 <0.001 – – – −0.05 −0.08, −0.03 <0.001 – – –
Summary score (of above 5 variables) −0.02 −0.02, −0.01 <0.001 – – – −0.01 −0.02, −0.01 <0.001 – – –
*Coefficient **Confidence Interval ***p value.
All a priori variables (HIV status, sex, age, ethnicity, born outside UK), as well as those with univariable p < 0.15 or multivariable p < 0.05 are presented here.
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In a model including young people with PHIV only,
factors associated with increased anxiety scores were
similar to the overall model, except that speaking a
language other than English was no longer significant
either univariably or multivariably (Table 5). Ever having
been excluded from school and social functioning were
no longer associated with higher depression scores,
whilst feeling less supported in relation to one’s HIV
status was associated with higher depression scores
(multivariable coefficient −0.04, 95%CI −0.06,−0.01),
whilst other coefficients changed minimally.
In the first and third sensitivity analyses, findings
were very similar (data not shown). In the second sensi-
tivity analysis, final multivariable model variables were
the same except that for anxiety the effect of sex became
significant (multivariable coefficient 0.21, 95%CI 0.04,
0.39), whilst for depression, it was no longer significant
(−0.01, 95%CI −0.19, 0.17).
Discussion
In our study of 283 PHIV and 96 HIV-affected young
people, with median age 16 years, overall anxiety and
depression scores were similar between the two groups,
both before and after adjustment for other variables. In
total 40% of PHIV and 31% of HIV-affected participants
scored mild to severe for anxiety and 16% and 17% mild
to moderate for depression. These results are similar to
other recent studies finding no evidence of a difference
in prevalence of mental health problems by HIV status,
(Elkington et al., 2011; Gadow et al., 2012; Mellins
et al., 2012; Mutumba et al., 2016) and suggest that con-
textual factors rather than HIV itself may have an impor-
tant role (Mellins & Malee, 2013). Another explanation
for the lack of difference by HIV status is that anxiety
and depression in young people with PHIV may be les-
sened through regular contact with health services and
mental health support (Gadow et al., 2012).
Prevalence of mental health problems in young people
with PHIV varies across different populations in the lit-
erature (Chernoff, Nachman, & Williams, 2009; Gadow
et al., 2012; Malee et al., 2011; Mellins et al., 2009;
Mutumba et al., 2016). This may be due to different men-
tal health problems being assessed, with differing defi-
nitions, and different healthcare settings and contextual
factors. In our study prevalence of mental health pro-
blems was similar to normative data, but two large
USA cohorts found higher prevalence in young people
with PHIV than young people in the general population
(Gadow et al., 2012; Mutumba et al., 2016). Both of these
studies used assessment tools which investigated a wider
range of psychiatric symptoms over more than one time
period, which may contribute to higher prevalence
compared to our study. In contrast, a third large cross-
sectional study from the USA found higher prevalence
of mental health problems in the HIV-affected group
compared to PHIV group at assessment (38% vs 25%,
p < 0.01), (Malee et al., 2011) using behavioural and
emotional symptom checklists, rather than psychiatric
assessments in the other studies.
Socio-demographic differences between the studies
also complicate the picture. In the USA many families
studied had a history of psychiatric disorders and sub-
stance-abuse, (Elkington et al., 2011; Malee et al., 2011)
whilst in the UK, most young people with PHIV were
born in sub-Saharan Africa, have migrated to the UK
(Bamford & Lyall, 2015) and there is no published evi-
dence of drug misuse in this group. These distinct experi-
ences may impact differently on the risk of anxiety and
depression.
Although young people with PHIV in our study
appear not to be at increased risk of anxiety or
depression symptoms compared to normative data,
40% scored at least mild symptoms of anxiety and simi-
larly, 15% scored at least mild symptoms of depression.
While it is reassuring that many young people with
PHIV appear to be coping well, mental health problems
in young people with PHIV may have an even more pro-
found effect than in other youth due to the wider health
implications associated with HIV. Mental health pro-
blems in young people with PHIV have been associated
with reduced adherence (Mutumba et al., 2016; Hudel-
son & Cluver, 2015) and retention in care (Lowenthal
et al., 2014) and increased sexual risk behaviours, (Kape-
tanovic et al., 2011; Mellins et al., 2011), highlighting the
need to identify young people at increased risk and pro-
viding the right support at the right time. Also of con-
cern, although levels of self-esteem were similar in the
PHIV and HIV-affected groups, they were nearly two
standard deviations lower than normative data, and
self-esteem was associated with both anxiety and
depression in multivariable models. Self-esteemmay bet-
ter reflect the long-term effects of cumulative adverse
factors to which these young people have been exposed,
than anxiety and depression.
A strength of our study was its ability to explore
associations between anxiety and depression scores and
a wide range of psychosocial factors in addition to HIV
status. In our analysis being male, having an increased
number of main carers during childhood, speaking a
language other than English at home, death of one or
both parents, ever having felt that life was not worth liv-
ing, lower self-esteem, worse social functioning and ever
having been excluded from school, were all related to
either higher anxiety and/ or depression scores. Some
other studies have found higher depression and anxiety
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in females compared to males, (Breeman, Cotton, Field-
ing, & Jones, 2015; Mellins & Malee, 2013; Mellins et al.,
2012; Mutumba et al., 2016; Paus, Keshavan, & Giedd,
2008) whilst others have not (Lewis, Abramowitz, Koe-
nig, Chandwani, & Orban, 2015; Malee et al., 2011).
Findings from studies of fostering suggest that multiple
placements are associated with later mental health pro-
blems, in keeping with a higher number of main carers
being associated with increased anxiety in our study
(Newton, Litrownik, & Landsverk, 2000; Rubin et al.,
2004). Speaking a language other than English at home
may reflect uncertain residency or negative effects of
immigration. The number of young people who had
experienced a close bereavement was high in this study
and may be further complicated in the context of having
HIV in the family (Battles & Wiener, 2002). The combi-
nation of higher anxiety scores and ever feeling life is not
worth living is certainly a concern because of the link
between unrecognised or untreated mental health pro-
blems and co-morbidities and suicide (Malee et al.,
2011; Thapar, Collishaw, Pine, & Thapar, 2012). Studies
have found that young people with PHIV are concerned
about disclosing their status to their peers which can lead
to feelings of isolation, (Battles & Wiener, 2002;
Mutumba et al., 2015) and better social support has
been found to improve psychological outcomes. One
large study found that young people who were excluded
from school had often experienced social disadvantage
including bereavements, and felt depressed and lonely
following educational exclusion (Berridge, Brodie, Pitts,
Porteous, & Tarling, 2001).
Our study has a number of limitations. Firstly we only
investigated anxiety and depression rather than a wider
range of psychiatric symptoms or mental health pro-
blems, as we were constrained by interview length,
which needed to be acceptable to young people. Our
analysis was cross-sectional, and there is a possibility
that symptoms of anxiety and depression contributed
to other mental health variables (e.g., self-esteem, self-
harm), rather than were outcomes, although our sensi-
tivity analysis had similar results. Selection of an appro-
priate tool to measure mental health was challenging
given the time constraints and that most tools are
designed either for children or adults. HADS is used
widely in the UK across chronic health conditions and
has some normative data in young adults. However
HADS is not a diagnostic tool as it dichotomises anxiety
and depression as two unrelated problems, and so is
more an indicator of psychological distress (Cosco,
Doyle, Ward, & McGee, 2012) which would require con-
firmatory psychological assessment for a formal diagno-
sis. Finally age-appropriate normative data were not
always available resulting in the downward extrapolation
of measures for use with younger ages; however, the
AALPHI cohort had its own control group of HIV-
affected young people, which formed the primary com-
parison group.
In conclusion, we found no difference in the preva-
lence of increased anxiety and depression scores between
PHIV and HIV-affected young people, and levels were
similar to UK normative data. However, for both
PHIV and HIV-affected young people levels of self-
esteem were significantly lower than population norms.
Key factors found to be associated with a greater anxiety
and depression scores included lower self-esteem, lower
social functioning, being male and having ever thought
life was not worth living. Our findings underscore the
need for young people with PHIV to be regularly
screened for mental health problems. Where routine
screening for anxiety and depression is not possible,
these key factors may be useful for clinical staff to help
identify a potentially more vulnerable sub-population
to monitor and prioritise for assessment.
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